Aa
Sofosbuvir / daclatasvir combination could be produced for $200
Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure
http://www.aidsmap.com/Sofosbuvir-daclatasvir-combination-could-be-produced-for-200-per-hepatitis-C-cure/page/3021833/
Keith Alcorn
Published: 14 December 2015
Excerpts ONLY - copy or select link right click via browser above and go there to read full article.
"Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs to cure hepatitis C for less than $200, Dr Andrew Hill of Liverpool University told the Second European HIV Hepatitis Co-infection Conference in London last week".
"In the case of sofosbuvir, they found that even assuming a 50% profit margin for the manufacturer to cover capital investment and return to shareholders, it would now be possible to sell a 12-week course of the drug for $178."
"These costings suggest that it would be possible to market a pan-genotypic combination of sofosbuvir and daclatasvir for no more than $200. But many of the middle-income countries with a high burden of hepatitis C, such as China, Brazil, Ukraine and Latin America, will continue to be excluded by the terms of voluntary licensing agreements from obtaining Indian generics – unless they pursue compulsory licensing. "
"In the case of hepatitis C treatment, people could take matters into their own hands without waiting for governments."
http://www.aidsmap.com/Sofosbuvir-daclatasvir-combination-could-be-produced-for-200-per-hepatitis-C-cure/page/3021833/
Keith Alcorn
Published: 14 December 2015
Excerpts ONLY - copy or select link right click via browser above and go there to read full article.
"Month-by-month tracking of the prices paid in India for the chemicals used to make hepatitis C direct-acting antivirals shows that it is now possible to make and sell a combination of drugs to cure hepatitis C for less than $200, Dr Andrew Hill of Liverpool University told the Second European HIV Hepatitis Co-infection Conference in London last week".
"In the case of sofosbuvir, they found that even assuming a 50% profit margin for the manufacturer to cover capital investment and return to shareholders, it would now be possible to sell a 12-week course of the drug for $178."
"These costings suggest that it would be possible to market a pan-genotypic combination of sofosbuvir and daclatasvir for no more than $200. But many of the middle-income countries with a high burden of hepatitis C, such as China, Brazil, Ukraine and Latin America, will continue to be excluded by the terms of voluntary licensing agreements from obtaining Indian generics – unless they pursue compulsory licensing. "
"In the case of hepatitis C treatment, people could take matters into their own hands without waiting for governments."
I'm shocked!
Shocked I say, that in the US, Big Pharm would grossly inflate prices on meds that are life-saving, giving the people with resources or great health insurance the option to be cured and letting those less fortunate and unable to pay for treatments, well, forgotten
Shocked I say, that in the US, Big Pharm would grossly inflate prices on meds that are life-saving, giving the people with resources or great health insurance the option to be cured and letting those less fortunate and unable to pay for treatments, well, forgotten
1 Comments
This combo is out in Egypt for $ 675 for 12 weeks
Have an Answer?
You are reading content posted in the Hepatitis C Community
Learn about this treatable virus.
Getting tested for this viral infection.
3 key steps to getting on treatment.
4 steps to getting on therapy.
What you need to know about Hep C drugs.
How the drugs might affect you.
These tips may up your chances of a cure.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
